Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHELA PAPILLON ANDERSON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1780022590
CMS profile
11079983
Location
DEERFIELD BEACH, FL

General Payments · PY2021–2024

$2,406.77

  • Reported across 56 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$636.55

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $343.86 15
Education $292.69 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $246.67 6
PY2022 $1,072.69 18
PY2023 $450.86 16
PY2024 $636.55 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARRAY BIOPHARMA INC $18.00 03/04/2024 Food and Beverage Undisputed 01/23/2026 1131734000 CMS
AstraZeneca Pharmaceuticals LP $27.30 04/09/2024 Food and Beverage Undisputed 01/23/2026 1105489731 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.35 02/06/2024 Food and Beverage Undisputed 01/23/2026 1086319062 CMS
Celgene Corporation $15.00 01/02/2024 Food and Beverage Undisputed 01/23/2026 1101158602 CMS
E.R. Squibb & Sons, L.L.C. $33.82 02/08/2024 Food and Beverage Undisputed 01/23/2026 1101580892 CMS
Genentech USA, Inc. $16.55 04/09/2024 Food and Beverage Undisputed 01/23/2026 1133187714 CMS
Genmab U.S., Inc. $24.10 02/26/2024 Food and Beverage Undisputed 01/23/2026 1126839076 CMS
Janssen Biotech, Inc. $26.58 03/25/2024 Food and Beverage Undisputed 01/23/2026 1078411573 CMS
JAZZ PHARMACEUTICALS INC. $22.50 02/27/2024 Food and Beverage Undisputed 01/23/2026 1151314565 CMS
Lilly USA, LLC $292.69 02/10/2024 Education Undisputed 01/23/2026 1135888992 CMS
Novartis Pharmaceuticals Corporation $15.00 04/03/2024 Food and Beverage Undisputed 01/23/2026 1086633703 CMS
PFIZER INC. $15.95 01/04/2024 Food and Beverage Undisputed 01/23/2026 1131722290 CMS
PUMA BIOTECHNOLOGY, INC. $24.29 03/28/2024 Food and Beverage Undisputed 01/23/2026 1113854936 CMS
Rigel Pharmaceuticals, Inc. $23.72 02/29/2024 Food and Beverage Undisputed 01/23/2026 1145200114 CMS
SOBI, INC $33.23 02/01/2024 Food and Beverage Undisputed 01/23/2026 1141416496 CMS
Sumitomo Pharma America, Inc. $26.47 01/26/2024 Food and Beverage Undisputed 01/23/2026 1148941673 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.